Exact Mass: 426.1414
Exact Mass Matches: 426.1414
Found 500 metabolites which its exact mass value is equals to given mass value 426.1414
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Anhydrotetracyclin
Mometasone
Mometasone is a medium-potency synthetic corticosteroid with antiinflammatory, antipruritic, and vasoconstrictive properties. Studies in asthmatic patients have demonstrated that mometasone provides a favorable ratio of topical to systemic activity due to its primary local effect along with the extensive hepatic metabolism and the lack of active metabolites. Though effective for the treatment of asthma, glucocorticoids do not affect asthma symptoms immediately. Maximum improvement in symptoms following inhaled administration of mometasone furoate may not be achieved for 1 to 2 weeks or longer after starting treatment. he antiinflammatory actions of corticosteroids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XC - Corticosteroids, potent, other combinations R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents
fluacrypyrim
Nicarbazin
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
6-(2-Carboxyethyl)-7-hydroxy-2,2-dimethyl-4-chromanone glucoside
6-(2-Carboxyethyl)-7-hydroxy-2,2-dimethyl-4-chromanone glucoside is found in herbs and spices. 6-(2-Carboxyethyl)-7-hydroxy-2,2-dimethyl-4-chromanone glucoside is a constituent of fennel, Foeniculum vulgare. Constituent of fennel, Foeniculum vulgare. 6-(2-Carboxyethyl)-7-hydroxy-2,2-dimethyl-4-chromanone glucoside is found in herbs and spices.
Chitobiose
Chitobiose is a dimer of beta-1,4-linked glucosamine units. There is ambiguity as to which structure the name refers, owing to the method by which it was first isolated. [HMDB] Chitobiose is a dimer of beta-1,4-linked glucosamine units. There is ambiguity as to which structure the name refers, owing to the method by which it was first isolated.
Butanoic acid, 3-((2-naphthalenylsulfonyl)amino)-4-oxo-4-((2-phenylethyl)amino)-, (S)-
Antibiotic M83
D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D008937 - Mitomycins
Garenoxacin
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2-(1H-imidazol-1-ylmethyl)-6-methyl-4-(3-nitrophenyl)-, 3-ethyl 5-methyl ester
Vericiguat
Yadanziolide A
yadanziolide A is a natural product found in Brucea javanica and Brucea mollis with data available. Yadanziolide A, isolated from the cultivated dry seeds of Brucea javanica, has strong antiviral activities with IC50 of 5.5 μM against tobacco mosaic virus. Yadanziolide A shows significant antitumor effects[1][2]. Yadanziolide A, isolated from the cultivated dry seeds of Brucea javanica, has strong antiviral activities with IC50 of 5.5 μM against tobacco mosaic virus. Yadanziolide A shows significant antitumor effects[1][2].
Villosinol
11-Hydroxytephrosin
5-Hydroxy-8-(4-hydroxy-3,5-dimethoxyphenyl)-10-methoxy-2,2-dimethyl-2H,6H-benzo[1,2-b:5,4-b]dipyran-6-one
5-Hydroxy-3,8-dimethoxy-3,4-methylenedioxy-7-prenyloxyflavone
N-Fructosyl gamma-glutamyl-S-methylcysteine
Annotation level-3
(-)-spicigerolide|(1S,2S,3Z)-2-(acetyloxy)-1-[(1S,2S)-1,2-di(acetyloxy)propyl]-4-[(2R)-6-oxo-3,6-dihydro-2H-2-pyranyl]-3-butenyl acetate|(6R)-6-[(1Z,3S,4S,5S,6S)-(3,4,5,6-tetraacetoxyhept-1-enyl)]-5,6-dihydropyran-2-one|6R-[3S,4S.5S,6S-tetraacetyloxy-1Z-heptenyl]-5,6-dihydro-2H-pyran-2-one|spicigerolide
N,2,3,5-Tetra-Ac-beta-D-5-Amino-1-ribofuranosyl-1H-imidazole-4-carboxamide
2-acetyl-1,3-dicoumaroylglycerol|2-acetyl-1,3-di[(E)-p-coumaroyl]glycerol|Lasiocarpin A
O-(6-O-Caffeoyl-beta-D-glucopyranoside)-(S)-4-Hydroxy-2-pentanone
(1R,2S,3R,4S)-1-Ac,1,3-debenzoyl-5-(Hydroxymethyl)-5-cyclohexene-1,2,3,4-tetrol|acetyl piperenol A
uvarirufol B|{(1R,4S,5R,6S)-6-acetoxy-1,4-dihydroxy-5-[(benzoyl)oxy]cyclohex-2-en-1-yl}methyl benzoate
(1R,2R,5R,6S,E)-1-((R)-6-oxo-3,6-dihydro-2H-pyran-2-yl)hept-3-ene-1,2,5,6-tetryl tetraacetate|6R-<1R,2R,5R,6S-(tetraacetyloxy)-3E-heptenyl>-5,6-dihydro-2H-pyran-2-one|6R-[1R,2R,5R,6S-(tetraacetyloxy)-3E-heptenyl]-5,6-dihydro-2H-pyran-2-one|6R-[1S,2R,5R,6S-(tetraacetyloxy)-3E-heptenyl]-5,6-dihydro-2H-pyran-2-one
4-O-(4-hydroxyprenyl)-caffeic acid 4-O-beta-D-glucopyranoside|4-O-<4-hydroxyprenyl>-caffeic acid 4-O-beta-D-glucopyranoside
(-)-6-acetylzeylenol|(-)-6-O-acetyl-1-benzoyloxymethylcyclohex-4-en-1,2,3,6-tetrol
(2R,3S)-6-acetyl-2-[1-O-(beta-D-glucopyranosyl)-2-propenyl]-5-hydroxy-3-methoxy-2,3-dihydrobenzofuran
2-(1,3-Benzodioxole-5-yl)-3,5-dimethoxy-7-(2-hydroxy-3-methyl-3-butenyloxy)-4H-1-benzopyran-4-one
5-O-beta-D-glucopyranosyl-1,3,8-trihydroxy-5,6,7,8-tetrahydroxanthone
(2S)-3-methyl-3-butene-1,2-diol 1-O-(6-caffeoyl)-beta-D-glucopyranoside|rotundarpenoside A
4-caffeoyl-3-methyl-but-2-ene-1,4-diol 1-O-beta-D-glucopyranoside|rotundarpenoside B
(-)-deguoic acid|5-(6,7-dimethoxy-2,3-dihydrochromon-3-oxy) beta-tubaic acid
(-)-rotoic acid|4-(2,3-dihydro-6,7-dimethoxychromon-3-oxy) tubaic acid
4(S)-(6-O-Caffeoyl-beta-D-glucopyranosyl)-2-pentanone
(-)-8-[(2S),3-dihydroxy-3-methylbutyl]-7-hydroxychromen-2-one 7-O-beta-D-glucopyranoside|devenyoside B
N-[4-(4-Hydroxybenzoylamino)butyl]-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxopteridine-6-carboxamide
Fmoc-Trp-OH
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.268 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.264
C20H26O10_2-(beta-D-Glucopyranosyloxy)benzyl 1,6-dihydroxy-2-cyclohexene-1-carboxylate
[8-[2-(3-methylbut-2-enoyloxy)propan-2-yl]-2-oxo-8,9-dihydrofuro[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate [IIN-based: Match]
[8,8-dimethyl-9-(3-methylbut-2-enoyloxy)-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] 3-methylbut-2-enoate [IIN-based on: CCMSLIB00000846416]
[8-[2-(3-methylbut-2-enoyloxy)propan-2-yl]-2-oxo-8,9-dihydrofuro[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate [IIN-based on: CCMSLIB00000845537]
[8-[2-(3-methylbut-2-enoyloxy)propan-2-yl]-2-oxo-8,9-dihydrofuro[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate [IIN-based on: CCMSLIB00000845540]
[8,8-dimethyl-9-(3-methylbut-2-enoyloxy)-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] 3-methylbut-2-enoate [IIN-based: Match]
[8,8-dimethyl-9-(3-methylbut-2-enoyloxy)-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] 3-methylbut-2-enoate_major
[8,8-dimethyl-9-(3-methylbut-2-enoyloxy)-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] 3-methylbut-2-enoate_98.9\\%
Ala Ala Cys Tyr
Ala Ala Tyr Cys
Ala Cys Ala Tyr
Ala Cys Phe Ser
Ala Cys Ser Phe
Ala Cys Tyr Ala
Ala Phe Cys Ser
Ala Phe Ser Cys
Ala Ser Cys Phe
Ala Ser Phe Cys
Ala Tyr Ala Cys
Ala Tyr Cys Ala
Cys Ala Ala Tyr
Cys Ala Phe Ser
Cys Ala Ser Phe
Cys Ala Tyr Ala
Cys Cys Thr Thr
Cys Phe Ala Ser
Cys Phe Gly Thr
Cys Phe Ser Ala
Cys Phe Thr Gly
Cys Gly Phe Thr
Cys Gly Thr Phe
Cys Met Ser Ser
Cys Ser Ala Phe
Cys Ser Phe Ala
Cys Ser Met Ser
Cys Ser Ser Met
Cys Thr Cys Thr
Cys Thr Phe Gly
Cys Thr Gly Phe
Cys Thr Thr Cys
Cys Tyr Ala Ala
Phe Ala Cys Ser
Phe Ala Ser Cys
Phe Cys Ala Ser
Phe Cys Gly Thr
Phe Cys Ser Ala
Phe Cys Thr Gly
Phe Gly Cys Thr
Phe Gly Thr Cys
Phe Ser Ala Cys
Phe Ser Cys Ala
Phe Thr Cys Gly
Phe Thr Gly Cys
Gly Cys Phe Thr
Gly Cys Thr Phe
Gly Phe Cys Thr
Gly Phe Thr Cys
Gly Gly Met Tyr
Gly Gly Tyr Met
Gly Met Gly Tyr
Gly Met Tyr Gly
Gly Thr Cys Phe
Gly Thr Phe Cys
Gly Tyr Gly Met
Gly Tyr Met Gly
Met Cys Ser Ser
Met Gly Gly Tyr
Met Gly Tyr Gly
Met Ser Cys Ser
Met Ser Ser Cys
Met Tyr Gly Gly
Ser Ala Cys Phe
Ser Ala Phe Cys
Ser Cys Ala Phe
Ser Cys Phe Ala
Ser Cys Met Ser
Ser Cys Ser Met
Ser Phe Ala Cys
Ser Phe Cys Ala
Ser Met Cys Ser
Ser Met Ser Cys
Ser Ser Cys Met
Ser Ser Met Cys
Thr Cys Cys Thr
Thr Cys Phe Gly
Thr Cys Gly Phe
Thr Cys Thr Cys
Thr Phe Cys Gly
Thr Phe Gly Cys
Thr Gly Cys Phe
Thr Gly Phe Cys
Thr Thr Cys Cys
Tyr Ala Ala Cys
Tyr Ala Cys Ala
Tyr Cys Ala Ala
Tyr Gly Gly Met
Tyr Gly Met Gly
Tyr Met Gly Gly
(+)-Tephrorin A
A monomethoxyflavanone that is (2S)-7-methoxyflavanone substituted at position 8 by a tetrahydrofuran ring which in turn is substituted by geminal methyl groups at position 2, an acetoxy group at position 3 and a hydroxy group at position 5. Isolated from Tephrosia purpurea, it exhibits antineoplastic activity.
Anhydrotetracycline
mangostanol
Edulisin II
6-(2-Carboxyethyl)-7-hydroxy-2,2-dimethyl-4-chromanone glucoside
Atrovirisidone
Mangostenol
2,2-(5-Bromo-2-fluoro-1,3-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
Cetotiamine
(3-ETHOXYCARBONYL-2-OXOPROPLY)TRIPHENYLPHOSPHONIUM CHLORIDE
Fenbenicillin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
2-benzofuran-1,3-dione,2,2-dimethylpropane-1,3-diol,furan-2,5-dione,propane-1,2-diol
N-(phenylsulphonyl)anthranilic acid, compound with 2,2,2-nitrilotriethanol (1:1)
Garenoxacin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
2-(4-methoxyphenyl)-4,6-diphenylpyrylium tetrafluoroborate
1,3-diisocyanato-2-methylbenzene,hexanedioic acid,2-(2-hydroxyethoxy)ethanol
2,4-DIFLUORO-N-(2-METHOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)BENZENESULFONAMIDE
U0126-EtOH
U0126 (U0126-EtOH) is a potent, non-ATP competitive and selective MEK1 and MEK2 inhibitor, with IC50s of 72 nM and 58 nM, respectively. U0126 is an autophagy and mitophagy inhibitor[1][2][3][4].
1,5-DI-O-(4-METHYLBENZOYL)-2,3-O-ISOPROPYLIDENE-BETA-D-RIBOFURANOSE
Benzenamine,4-[(2-chlorophenyl)[4-(ethylimino)-3-methyl-2,5-cyclohexadien-1-ylidene]methyl]-N-ethyl-2-methyl-,hydrochloride (1:1)
(1S)-1,5-Anhydro-1-{4-methyl-3-[(5-phenyl-2-thienyl)methyl]phenyl}-D-glucitol
p-Nitrophenyl 2-Acetamido-2-deoxy-3,6-di-O-acetyl-β-D-glucopyranoside
(S,S)-1,2-Bis[(o-tolyl)(phenylphosphino)]ethane,(S,S)-1,2-Ethanediylbis[(2-methylphenyl)phenylphosphine]
Pregna-1,4-diene-3,20-dione,9,11-dichloro-17,21-dihydroxy-16-methyl-, (11b,16a)-
4-Epianhydrotetracycline
4-Epianhydrotetracycline. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=7518-17-4 (retrieved 2024-10-30) (CAS RN: 7518-17-4). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
N-(1-(2,2-DIFLUORO-2-(4-(TRIFLUOROMETHYL)PHENYL)ETHYL)PIPERIDIN-4-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE
Vericiguat
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
1-Cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
N-[2-[2-(3-methoxyphenoxy)anilino]-2-oxoethyl]naphthalene-1-carboxamide
N-[(5-imino-3-methyl-1-phenyl-4-pyrazolylidene)amino]-3-(4-morpholinylsulfonyl)aniline
2-(((9H-Fluoren-9-yl)methoxy)carbonylamino)-3-(1H-indol-3-yl)propanoic acid
N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan
4,18-Dihydroxy-15-(3-hydroxy-3-methylbutyl)-2-methoxy-7,9,13-trioxapentacyclo[10.8.0.03,10.04,8.014,19]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
(1S,4aS,12aS)-3-carbamoyl-1-(dimethylammonio)-4a,6,7-trihydroxy-11-methyl-4,5-dioxo-1,4,4a,5,12,12a-hexahydrotetracen-2-olate
1,3,6-trihydroxy-2-[(2R)-2-hydroxy-3-methylbut-3-enyl]-7-methoxy-8-(3-methylbut-2-enyl)xanthen-9-one
3-(2-fluorophenyl)-6-[4-methoxy-3-(3-oxolanyloxy)phenyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
(E)-N-[[4-(morpholin-4-ylmethyl)phenyl]carbamothioyl]-3-(3-nitrophenyl)prop-2-enamide
3-[[2-[4-(3-chlorophenyl)-1-piperazinyl]-1-oxoethyl]amino]-1H-indole-2-carboxylic acid methyl ester
3-[[2-[[4-Ethyl-5-[(3-methylphenoxy)methyl]-1,2,4-triazol-3-yl]thio]-1-oxoethyl]amino]benzoic acid
2-[[5-(4-fluorophenyl)-1-methyl-2-imidazolyl]thio]-N-[2-(4-morpholinyl)phenyl]acetamide
2-[[2-[(3,7-Dimethyl-2-quinolinyl)thio]-1-oxoethyl]amino]-4,5-dimethoxybenzoic acid
N-[4-methyl-3-(1-piperidinylsulfonyl)phenyl]-4-oxo-1-benzopyran-2-carboxamide
N-[3-(1-azepanylsulfonyl)phenyl]-4-oxo-1-benzopyran-2-carboxamide
2-(4-oxo-3-quinazolinyl)-N-[3-(1-piperidinylsulfonyl)phenyl]acetamide
[(9R)-8-[2-[(Z)-2-Methylbut-2-enoyl]oxypropan-2-yl]-2-oxo-8,9-dihydrofuro[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate
2-[4-(5-{[(2-Methylphenyl)sulfonyl]methyl}-2-furoyl)piperazin-1-yl]pyrimidine
1-(2-Fluorophenyl)-5-[[4-(4-morpholinyl)anilino]methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione
ethyl (2Z)-2-[(5Z)-3-[2-(furan-2-ylmethylamino)-2-oxoethyl]-5-[(4-methylphenyl)methylidene]-4-oxo-1,3-thiazolidin-2-ylidene]acetate
[1-methyl-1-[(9R)-9-(3-methylbut-2-enoyloxy)-2-oxo-8,9-dihydrofuro[2,3-h]chromen-8-yl]ethyl] (E)-2-methylbut-2-enoate
N-cyclohexyl-2-[(2R,3S,6S)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-cyclohexyl-2-[(2S,3S,6R)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-cyclohexyl-2-[(2S,3R,6S)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-cyclohexyl-2-[(2R,3R,6R)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-cyclohexyl-2-[(2S,3S,6S)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
N-cyclohexyl-2-[(2S,3R,6R)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-cyclohexyl-2-[(2R,3S,6R)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-cyclohexyl-2-[(2R,3R,6S)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
(1R,5S)-7-[4-(2-fluorophenyl)phenyl]-6-(3-fluorophenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane
3,4,5-Trihydroxy-6-[2-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]propanoyl]oxyoxane-2-carboxylic acid
6-[3-(1,2-Dihydroxybutyl)-1-oxoisochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
15-(1,3-Dihydroxy-3-methylbutyl)-18-hydroxy-2-methoxy-7,9,13-trioxapentacyclo[10.8.0.03,10.04,8.014,19]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
1,3,5-Benzenetricarboxylic acid tri(trimethylsilyl) ester
13,21-Dihydroxy-16,17-dimethoxy-6-prop-1-en-2-yl-2,7,20-trioxapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one
2-(4-(4-Nitrophenyl)-6-phenyl-2-pyrimidinylamino)benzoic acid methyl ester
1,2,3-Benzenetricarboxylic acid tri(trimethylsilyl) ester
4,7-DI(Para-methoxyphenyl)-6-(pyridin-4-YL)-1,2,5-thiadiazolo(3,4-C)pyridine
[8-[2-(3-methylbut-2-enoyloxy)propan-2-yl]-2-oxo-8,9-dihydrofuro[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate
Mometasone
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XC - Corticosteroids, potent, other combinations R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents
anhydrotetracycline zwitterion
Zwitterionic form of anhydrotetracycline arising from transfer of a proton from the 2-hydroxy to the tertiary amino group; major species at pH 7.3.
Archangelicin
S-butyryl-4-phosphopantetheine(2-)
An S-acyl-4-phosphopantetheine obtained by deprotonation of the phosphate OH groups of S-butyryl-4-phosphopantetheine; major species at pH 7.3.
(2r,3s)-3-[(1s,14s,15r)-11-hydroxy-4,12,14,15-tetramethyl-3,6-dioxo-8,16-dioxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-2(7),4,9(17),10,12-pentaen-5-yl]butan-2-yl formate
1,3,6-trihydroxy-2-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-5-methoxy-7-(3-methylbut-2-en-1-yl)xanthen-9-one
3-(4-hydroxy-2-methyl-6-oxocyclohexyl)-6a-methyl-9-(2-methylbutanoyl)furo[2,3-h]isochromene-6,8-dione
6-(2,3-dihydroxy-3-methylbutyl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
2,5-bis(acetyloxy)-7-[3-(acetyloxy)-6-oxo-2,3-dihydropyran-2-yl]hept-6-en-3-yl acetate
(1r,4s,5r,6s)-6-(acetyloxy)-5-[(benzoyloxy)methyl]-4,5-dihydroxycyclohex-2-en-1-yl benzoate
5-hydroxy-4-(7-methoxy-4-oxo-2-phenyl-2,3-dihydro-1-benzopyran-8-yl)-2,2-dimethyloxolan-3-yl acetate
(9s,10s)-8,8-dimethyl-10-{[(2z)-2-methylbut-2-enoyl]oxy}-2-oxo-9h,10h-pyrano[2,3-h]chromen-9-yl (2z)-2-methylbut-2-enoate
2-[(1r,2r)-1,2-dihydroxypropyl]-7-methoxy-5-methyl-8-[(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
8,8-dimethyl-10-[(2-methylbut-2-enoyl)oxy]-2-oxo-9h,10h-pyrano[2,3-h]chromen-9-yl 3-methylbut-2-enoate
6-(acetyloxy)-2-[(benzoyloxy)methyl]-4,5-dihydroxycyclohex-2-en-1-yl benzoate
5-(2-hydroxy-1-methanesulfonylpropan-2-yl)-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
(1r,14r)-11,14-dihydroxy-17,18-dimethoxy-7,7-dimethyl-2,8,21-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁵,²⁰]docosa-3,5,9,11,15(20),16,18-heptaen-13-one
3-(2-{[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}propyl)-8-hydroxy-6-methoxyisochromen-1-one
(3s)-3-ethyl-7-hydroxy-3,6-dimethyl-1-oxo-2-benzofuran-5-yl 6-[(2e)-but-2-en-2-yl]-2,4-dihydroxy-3-methylbenzoate
6-[(6,8-dihydroxy-3,7-dimethyl-1-oxo-3,4-dihydro-2-benzopyran-5-yl)methyl]-5-hydroxy-7-methoxy-2-methylchromen-4-one
6-{[(3r)-6,8-dihydroxy-3,7-dimethyl-1-oxo-3,4-dihydro-2-benzopyran-5-yl]methyl}-5-hydroxy-7-methoxy-2-methylchromen-4-one
3,6-bis(acetyloxy)-1-[3-(acetyloxy)-6-oxo-2,3-dihydropyran-2-yl]hept-1-en-4-yl acetate
3,6,8-trihydroxy-2-methoxy-1-({1,3,3-trimethyl-7-oxabicyclo[2.2.1]heptan-2-yl}methyl)xanthen-9-one
9-(hydroxymethyl)-3,6-dimethyl-2,7-dioxo-3h,3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-(4-methoxyphenyl)acetate
1-[(2r,3s)-5-hydroxy-3-methoxy-2-(3-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-6-yl]ethanone
6-[(2s)-2,3-dihydroxy-3-methylbutyl]-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
2,3,12,15,16-pentahydroxy-17-(hydroxymethyl)-9,13-dimethyl-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadec-9-ene-4,11-dione
(1r,2r,3r,6s,7r,8s,12s,13s,14r,15r,16s,17r)-2,3,7,12,15,16-hexahydroxy-9,13,17-trimethyl-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadec-9-ene-4,11-dione
2-(2h-1,3-benzodioxol-5-yl)-5-hydroxy-3,8-dimethoxy-7-[(3-methylbut-2-en-1-yl)oxy]chromen-4-one
3-{3-hydroxy-4-[(3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-en-1-yl)oxy]phenyl}prop-2-enoic acid
7-hydroxy-6-(2-hydroxy-3-methyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)chromen-2-one
(2r,2's,4s,6s,7s,10s,12s)-2',12,17-trihydroxy-6-methyl-3,8-dioxaspiro[hexacyclo[11.8.0.0²,⁴.0²,¹⁰.0⁶,¹⁰.0¹⁴,¹⁹]henicosane-7,3'-oxolane]-1(13),14,16,18-tetraene-5',20-dione
2-[(1r,2s)-1,2-dihydroxypropyl]-7-methoxy-5-methyl-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
(3s)-3,5,9-trihydroxy-8-methoxy-2,2-dimethyl-7-(3-methylbut-2-en-1-yl)-3,4-dihydro-1,11-dioxatetracen-6-one
1,3,6-trihydroxy-2-(4-hydroxy-3-methylbut-2-en-1-yl)-7-methoxy-8-(3-methylbut-2-en-1-yl)xanthen-9-one
10-{[2-(4-hydroxyphenyl)ethyl]amino}-5,11-dimethoxy-16-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one
3-[(2s)-2-{[(2r,3s,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}propyl]-8-hydroxy-6-methoxyisochromen-1-one
7-hydroxy-8-[(2r)-2-hydroxy-3-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]chromen-2-one
(3r)-3-(2h-1,3-benzodioxol-5-yl)-1-(5,8-dimethoxy-2,2-dimethylchromen-6-yl)-3-methoxypropan-1-one
7,12-dihydroxy-10-(3-hydroxy-3-methylbutyl)-9-methoxy-2,2-dimethyl-1,11-dioxatetracen-6-one
11-hydroxytephrosin
{"Ingredient_id": "HBIN000455","Ingredient_name": "11-hydroxytephrosin","Alias": "NA","Ingredient_formula": "C23H22O8","Ingredient_Smile": "CC1(C=CC2=C(O1)C=C(C3=C2OC4COC5=CC(=C(C=C5C4(C3=O)O)OC)OC)O)C","Ingredient_weight": "426.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10740","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "124355889","DrugBank_id": "NA"}
[(6R,7S)-8,8-dimethyl-7-(3-methylbut-2-enoyloxy)-2-oxo-6,7-dihydropyrano[5,6-g]chromen-6-yl] 3-methylbut-2-enoate
{"Ingredient_id": "HBIN012782","Ingredient_name": "[(6R,7S)-8,8-dimethyl-7-(3-methylbut-2-enoyloxy)-2-oxo-6,7-dihydropyrano[5,6-g]chromen-6-yl] 3-methylbut-2-enoate","Alias": "3-methylbut-2-enoic acid [(6R,7S)-8,8-dimethyl-7-(3-methyl-1-oxobut-2-enoxy)-2-oxo-6,7-dihydropyrano[5,6-g]chromen-6-yl] ester; 3-methylbut-2-enoic acid [(6R,7S)-2-keto-8,8-dimethyl-7-(3-methylbut-2-enoyloxy)-6,7-dihydropyrano[5,6-g]chromen-6-yl] ester","Ingredient_formula": "C24H26O7","Ingredient_Smile": "NA","Ingredient_weight": "426.46","OB_score": "48.72928062","CAS_id": "23027-48-7","SymMap_id": "SMIT13867","TCMID_id": "NA","TCMSP_id": "MOL013177","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
archangelicin
{"Ingredient_id": "HBIN016605","Ingredient_name": "archangelicin","Alias": "[1-methyl-1-[(9R)-9-(3-methylbut-2-enoyloxy)-2-oxo-8,9-dihydrofuro[2,3-h]chromen-8-yl]ethyl] (E)-2-methylbut-2-enoate; CHEBI:2808","Ingredient_formula": "C24H26O7","Ingredient_Smile": "CC=C(C)C(=O)OC1C(OC2=C1C3=C(C=C2)C=CC(=O)O3)C(C)(C)OC(=O)C(=CC)C","Ingredient_weight": "426.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT01274","TCMID_id": "1619","TCMSP_id": "NA","TCM_ID_id": "6709","PubChem_id": "133562226","DrugBank_id": "NA"}